The Phase II Small Business Innovation Research grant will fund further research and production of a positron emission tomography, or PET, agent that can be used to diagnose and manage brain tumors and potentially to diagnose many other common diseases, including Parkinson???s, Alzheimer???s and many forms of cancer.